[Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis].
Kalishevskaia
T M
TM
Golubeva
M G
MG
Bashkov
G V
GV
Vinter
V B
VB
D000818:Animals; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000188:drug therapy; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005341:Fibrinolysin / Q000627:therapeutic use*; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents; D006493:Heparin / Q000627:therapeutic use*; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy
D004338:Drug Combinations; D005343:Fibrinolytic Agents; D011942:Receptors, Adrenergic, alpha; D004088:Dihydroergotoxine; D006493:Heparin; D005341:Fibrinolysin
Vliianie kombinatsii fibrinolizina, geparina i kompleksa fibrinolizin-geparin s digidroérgotoksinom na trombolizis.